These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 15337423)

  • 1. Molecular imaging in breast cancer.
    Schuster DM; Halkar RK
    Radiol Clin North Am; 2004 Sep; 42(5):885-908, vi-vii. PubMed ID: 15337423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positron emission tomography for the diagnosis of breast cancer.
    Rosé C; Dose J; Avril N
    Nucl Med Commun; 2002 Jul; 23(7):613-8. PubMed ID: 12089482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Positron emission tomography (PET) in diagnosis of breast carcinoma].
    Ivancevic V
    Zentralbl Chir; 1998; 123 Suppl 5():53-6. PubMed ID: 10063574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDG-PET and beyond: molecular breast cancer imaging.
    Quon A; Gambhir SS
    J Clin Oncol; 2005 Mar; 23(8):1664-73. PubMed ID: 15755974
    [No Abstract]   [Full Text] [Related]  

  • 5. Diagnosis of recurrent and metastatic disease using f-18 fluorodeoxyglucose-positron emission tomography in breast cancer.
    Eubank WB
    Radiol Clin North Am; 2007 Jul; 45(4):659-67, vi. PubMed ID: 17706530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging.
    Gallowitsch HJ; Kresnik E; Gasser J; Kumnig G; Igerc I; Mikosch P; Lind P
    Invest Radiol; 2003 May; 38(5):250-6. PubMed ID: 12750613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 18-FDG imaging in breast cancer.
    Hoh CK; Schiepers C
    Semin Nucl Med; 1999 Jan; 29(1):49-56. PubMed ID: 9990683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging in breast cancer: Single-photon computed tomography and positron-emission tomography.
    Bénard F; Turcotte E
    Breast Cancer Res; 2005; 7(4):153-62. PubMed ID: 15987467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of positron emission tomography/computed tomography in breast cancer.
    Bourgeois AC; Warren LA; Chang TT; Embry S; Hudson K; Bradley YC
    Radiol Clin North Am; 2013 Sep; 51(5):781-98. PubMed ID: 24010906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [FDG-PET (positron emission tomography) in the detection of primary breast cancer and lymph node involvement].
    Koga S; Nakano S; Honma Y; Ogasawara N
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():379-84. PubMed ID: 17682181
    [No Abstract]   [Full Text] [Related]  

  • 11. Radioimmunolocalization of primary and metastatic breast cancer.
    Baum RP; Brümmendorf TH
    Q J Nucl Med; 1998 Mar; 42(1):33-42. PubMed ID: 9646643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new look at breast cancer.
    Wagner HN
    J Nucl Med; 1999 Jun; 40(6):1009-10. PubMed ID: 10452319
    [No Abstract]   [Full Text] [Related]  

  • 13. Oncological applications of FDG PET imaging.
    Delbeke D
    J Nucl Med; 1999 Oct; 40(10):1706-15. PubMed ID: 10520713
    [No Abstract]   [Full Text] [Related]  

  • 14. Positron emission tomography, positron emission tomography-computed tomography, and molecular imaging of the breast cancer patient.
    Franc BL; Hawkins RA
    Semin Roentgenol; 2007 Oct; 42(4):265-79. PubMed ID: 17919529
    [No Abstract]   [Full Text] [Related]  

  • 15. Imaging breast cancer.
    Bartella L; Smith CS; Dershaw DD; Liberman L
    Radiol Clin North Am; 2007 Jan; 45(1):45-67. PubMed ID: 17157623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear imaging and early breast cancer detection.
    Evangelista L; Cervino AR
    Curr Radiopharm; 2014; 7(1):29-35. PubMed ID: 24836945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PET imaging in breast cancer.
    Bombardieri E; Crippa F
    Q J Nucl Med; 2001 Sep; 45(3):245-56. PubMed ID: 11788817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorodeoxyglucose-PET in the management of breast cancer.
    Kumar R; Alavi A
    Radiol Clin North Am; 2004 Nov; 42(6):1113-22, ix. PubMed ID: 15488561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of whole body 18F-fluoro-2-deoxyglucose positron emission tomography in the evaluation of recurrent cervical cancer.
    Sun SS; Chen TC; Yen RF; Shen YY; Changlai SP; Kao A
    Anticancer Res; 2001; 21(4B):2957-61. PubMed ID: 11712793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of combined FDG PET and MR imaging in the evaluation of suspected recurrent local-regional breast cancer: preliminary experience.
    Hathaway PB; Mankoff DA; Maravilla KR; Austin-Seymour MM; Ellis GK; Gralow JR; Cortese AA; Hayes CE; Moe RE
    Radiology; 1999 Mar; 210(3):807-14. PubMed ID: 10207485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.